CS logo
small CS logo
Radhuset Spesialistsenter

Oslo, Norway
Hjertespesialist i Oslo

About Radhuset Spesialistsenter


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Kowa Research Europe
3
Boehringer Ingelheim
1
Total Rows: 2

Clinical Trials at Radhuset Spesialistsenter


During the past decade, Radhuset Spesialistsenter conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
857
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Radhuset Spesialistsenter" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsKowa Research Europe: 3Kowa Research Europe: 3Boehringer Ingelheim: 1Boehringer Ingelheim: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 1Eli Lilly and Company: 1

Clinical Trials Conditions at Radhuset Spesialistsenter


According to Clinical.Site data, the most researched conditions in "Radhuset Spesialistsenter" are "Dyslipidemia" (3 trials), "Hypercholesterolemia" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Primary Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Radhuset Spesialistsenter" in a lesser frequency.

Clinical Trials Intervention Types at Radhuset Spesialistsenter


Most popular intervention types in "Radhuset Spesialistsenter" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Pitavastatin" (3 trials), "Atorvastatin" (1 trials), "Simvastatin" (1 trials), "glimepiride" (1 trials) and "glimepiride placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Radhuset Spesialistsenter


The vast majority of trials in "Radhuset Spesialistsenter" are 4 trials for "All" genders.

Clinical Trials Status at Radhuset Spesialistsenter


Currently, there are NaN active trials in "Radhuset Spesialistsenter". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Radhuset Spesialistsenter, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Radhuset Spesialistsenter, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4